• Evaluation of current health situation - symptoms, medications and therapy reactions
• Assessment of possible adequacy of the recovery process
• Initiation of Physician's focus to treat the onset of chronic situations or severity of the diseases
• Evaluation of the prognosis and treatment outcomes
• Identification of abnormalities in cardiovascular, cerebrovascular system and overall health assessment
• Blood circulatory status - age of blood vessels based on arterial elasticity, peripheral circulatory rate, organic/functional abnormality of the blood vessels
• Prediction and progression of Arteriosclerosis, Obesity, Hypertension, Hyperlipidemia and Diabetes
• Useful as a health barometer

• Monitoring current health of the individual patient closely
• Verifying the efficacy of current treatment protocol and intervention
• Examining patients for Cardiac Autonomic Neuropathy (CAN) and Diabetes Autonomic Neuropathy (DAN)
• Measuring the Metabolic Syndrome, Hypertension, Heart Failure
• Predicting burn-out syndrome, anxiety, depression, psychological conditions
• Exploring Asthma, COPD, Palpitations, Pain management, Sleep apnea
• Optimization of treatment for each individual patient
• Immediate reports - qualitative, quantitative and graphic analysis and results of ANS balance, cardiovascular, stress, fitness and overall health assessment
• Comparisons with a patient case history and necessary procedural actions
• Efficient patient-centered multiple symptoms treatment management

VitalScan Combo Pro is a valuable tool in diagnosing hidden illnesses. Medical practitioners can quickly and easily test patients and receive immediate comprehensive interpretive reports.

• "According to Published Studies "Cardiovascular autonomic neuropathy occurs in about 17% of patients with type 1 diabetes and 22% of those with type 2"
• "Of patients with symptomatic autonomic dysfunction, 25% to 50% die within 1 to 5 years of diagnosis."
• "A patient's history and physical examination are ineffective for early detection of CAN, and therefore noninvasive tests that have demonstrated efficacy are required".
• "Screening for Autonomic Neuropathy should be instituted at Diagnosis of Type 2 Diabetes and 5 years after the diagnosis of type 1 Diabetes - 2005 ADA Standard of Diabetes Care"
• "Although it can cause severe cardiovascular problems and sudden death, surveys show that only 2% of people with diabetes are tested for cardiovascular autonomic neuropathy (CAN)".

• Cognitive function and impairment
• Biomarkers associated with cognitive impairment and memory loss
• Autonomic nervous system function
• Physiologic functions associated with sleep disorders, memory loss, anxiety disorders and attention difficulties

• The degree of cognitive impairment
• Physiologic changes in cognitive function over time
• Cognitive function response to clinical therapies

The ability to rapidly, inexpensively, and reliably measure the brain's functional health is vital in identifying numerous medical conditions. Before the BrainView system, the only brain assessment technology available that used EEG was not portable, used complicated accompanying software and was not practical to use in a busy medical practice. BrainView was developed from necessity to create a wireless, automated, rapidly deploying brain function measurement and treatment system that was also non-intrusive and low-cost.

Due to the test length of 25 minutes, the BrainView is ideal for primary care and specialty physicians caring for patients within their offices.

The BrainView system is a 21-channel EEG/ERP amplifier with a dedicated laptop and testing supplies. The system utilizes high-quality circuit boards and components to allow for high-quality brain measurements, as well as essential heart data (HRV).

The BrainView system is designed for technicians with any experience level to reliably record EEG, ERPs, and symptom inventories that are then analyzed and processed into valuable reports that assist the physician with evaluating patient conditions and changes to the treatment plan.

By providing world-class service, BrainView has marked its territory in the industry and is gaining popularity and the strong support of the international medical research community.

Health care providers often state that they feel overwhelmed by the seemingly endless preprocessing steps needed to get results from raw EEG signals. However, analyzing EEG data and designing optimal EEG paradigms requires a high level of expertise. Countless aspects need consideration. These include signal processing, feature extraction, attenuation, and artifact detection and removal.

BrainView combines industry-validated and innovative neuropsychological tests with simultaneous electroencephalography (EEG) recording. Our medical software rapidly analyzes and transforms the EEG's event-related potential (ERP) data into actionable insights on core cognitive functions.

BrainView is backed by over 30 years of globally celebrated, peer-reviewed scientific research.

BrainView system combines electrophysiological biomarkers associated with numerous cognitive conditions. It details known clinical correlation based on over 600 scientific publications and defines electroencephalography-derived metrics. Recommended medical interventions are based on these clinical correlations.